0
Skip to Content
SymbioCellTech
Home
Technology
Patent Portfolio
Publications
Species Specific Culture Medium
Pipeline
Board
Leadership
Contact
News
SymbioCellTech
Home
Technology
Patent Portfolio
Publications
Species Specific Culture Medium
Pipeline
Board
Leadership
Contact
News
Home
Folder: Intellectual Property
Back
Technology
Patent Portfolio
Publications
Species Specific Culture Medium
Pipeline
Folder: Company
Back
Board
Leadership
Contact
News
Travis Manning 6/30/17 Travis Manning 6/30/17

'Neo-Islets', a Major Advance Toward a Functional Cure for Type-1 Diabetes. SymbioCellTech Featured on the Cover of Stem Cells Translational Medicine

Read More
SymbioCellTech, LLC 5/31/17 SymbioCellTech, LLC 5/31/17

SymbioCellTech Treats First Pet Dog in FDA-approved Companion Animal Trial

Read More
Travis Manning 11/28/16 Travis Manning 11/28/16

SymbioCellTech recieves FDA approval to conduct pilot studies in pet dogs

Read More
Travis Manning 6/24/16 Travis Manning 6/24/16

SCT raises additional capital from angel investors to finance dog trials

Read More
Travis Manning 4/22/16 Travis Manning 4/22/16

SCT Submits FDA Application For Dog Trials

Read More
Travis Manning 4/6/16 Travis Manning 4/6/16

World Health Organization Publishes Global Report on Diabetes and Calls For Action

Read More
Travis Manning 12/7/15 Travis Manning 12/7/15

SCT Files New Patent for the Cure of Type-1 Diabetes

Read More
Travis Manning 8/15/14 Travis Manning 8/15/14

SymbioCellTech raises $2.5M seed funding

Read More
Travis Manning 3/13/14 Travis Manning 3/13/14

JDCA Highlights SymbioCellTech as a company developing a practical cure

Read More
Newer Posts

SymbioCellTech LLC, 615 Arapeen Drive, Salt Lake City, UT, 84108, United States   801.503.3990 or 801.643.5970   t.manning@symbocelltech.com

COPYRIGHT © 2019 - SymbioCellTech, LLC.